To evaluate whether genetic defects in TLR1, TLR2 and TLR4 may influence HMGB1-mediated antitumor immunity and be associated with distant metastasis and tumor relapse in advanced-stage CRC patients after chemotherapy treatment. The gene discussed is TLR1; the disease is neoplasm.